Perceptive Advisors’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-940
| Closed | -$2K | – | 177 |
|
|
2017
Q1 | $2K | Sell |
940
-292,520
| -100% | -$622K | ﹤0.01% | 155 |
|
|
2016
Q4 | $1.52M | Hold |
293,460
| – | – | 0.11% | 87 |
|
|
2016
Q3 | $1.64M | Sell |
293,460
-6,540
| -2% | -$36.4K | 0.11% | 91 |
|
|
2016
Q2 | $1.67M | Buy |
+300,000
| New | +$1.67M | 0.12% | 82 |
|
|
2015
Q3 | – | Sell |
-465,225
| Closed | -$2.85M | – | 189 |
|
|
2015
Q2 | $2.85M | Sell |
465,225
-174,000
| -27% | -$1.07M | 0.17% | 77 |
|
|
2015
Q1 | $5.15M | Buy |
639,225
+125,001
| +24% | +$1.01M | 0.4% | 47 |
|
|
2014
Q4 | $2.6M | Buy |
514,224
+459,151
| +834% | +$2.32M | 0.22% | 74 |
|
|
2014
Q3 | $286K | Hold |
55,073
| – | – | 0.03% | 86 |
|
|
2014
Q2 | $428K | Sell |
55,073
-6,190
| -10% | -$48.1K | 0.04% | 82 |
|
|
2014
Q1 | $428K | Hold |
61,263
| – | – | 0.05% | 84 |
|
|
2013
Q4 | $367K | Sell |
61,263
-88,737
| -59% | -$532K | 0.04% | 71 |
|
|
2013
Q3 | $1.17M | Hold |
150,000
| – | – | 0.1% | 56 |
|
|
2013
Q2 | $570K | Buy |
+150,000
| New | +$570K | 0.06% | 55 |
|